The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
Thursday, October 21, 2010
FDA orders new warnings on prostate cancer drugs
FDA orders new warnings on prostate cancer drugs: "WASHINGTON (Reuters) - Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday.
The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
"
The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
